A detailed history of Bollard Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bollard Group LLC holds 120,613 shares of BMY stock, worth $6.97 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
120,613
Previous 135,302 10.86%
Holding current value
$6.97 Million
Previous $5.62 Million 11.07%
% of portfolio
0.17%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $582,565 - $760,155
-14,689 Reduced 10.86%
120,613 $6.24 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $261,866 - $344,752
6,506 Added 5.05%
135,302 $5.62 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $135,255 - $153,353
2,819 Added 2.24%
128,796 $6.99 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $1.51 Million - $1.81 Million
-31,232 Reduced 19.87%
125,977 $6.46 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $640,437 - $716,107
-11,063 Reduced 6.57%
157,209 $9.12 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $75,432 - $83,756
1,184 Added 0.71%
168,272 $10.8 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $58,284 - $66,108
887 Added 0.53%
167,088 $11.6 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $539,896 - $639,313
-7,884 Reduced 4.53%
166,201 $12 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $113 - $67,158
874 Added 0.5%
174,085 $12.4 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $79,373 - $87,418
1,093 Added 0.64%
173,211 $13.3 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $722,205 - $865,988
11,747 Added 7.32%
172,118 $12.6 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $62,961 - $73,398
1,174 Added 0.74%
160,371 $10 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $487,915 - $571,530
8,246 Added 5.46%
159,197 $9.42 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $688,253 - $749,508
11,117 Added 7.95%
150,951 $10.1 Million
Q1 2021

May 11, 2021

BUY
$59.34 - $66.74 $48,658 - $54,726
820 Added 0.59%
139,834 $8.83 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $45,210 - $51,231
783 Added 0.57%
139,014 $8.62 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $27,623 - $30,610
481 Added 0.35%
138,231 $8.33 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $109 - $128
2 Added 0.0%
137,750 $8.1 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $26,726 - $38,839
576 Added 0.42%
137,748 $7.68 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $27,803 - $36,267
565 Added 0.41%
137,172 $8.81 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $2.32 Million - $2.75 Million
-54,230 Reduced 28.42%
136,607 $6.93 Million
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $2.57 Million - $2.84 Million
-57,508 Reduced 23.16%
190,837 $8.65 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $1.25 Million - $1.49 Million
27,745 Added 12.58%
248,345 $11.8 Million
Q4 2018

Feb 05, 2019

BUY
$48.76 - $63.23 $529,436 - $686,551
10,858 Added 5.18%
220,600 $11.5 Million
Q3 2018

Nov 08, 2018

BUY
$55.19 - $62.25 $487,217 - $549,543
8,828 Added 4.39%
209,742 $13 Million
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $191,458 - $238,631
3,789 Added 1.92%
200,914 $11.1 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $405,718 - $467,063
6,771 Added 3.56%
197,125 $12.5 Million
Q4 2017

Jan 29, 2018

SELL
$59.94 - $65.35 $76,783 - $83,713
-1,281 Reduced 0.67%
190,354 $11.7 Million
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $10.6 Million - $12.2 Million
191,635
191,635 $12.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.